-->
打开APP

2018 (4th) International Symposium on Next-Generation CAR & TCR-T Cells

2018-11-23

Chimeric antigen receptors?are engineered?receptors?that combine a new specificity with an?immune cell?to target cancer cells. Typically, these receptors graft the specificity of a?monoclonal antibody?onto a?T cell. CAR-T cells are a new type of treatment that uses living cells that have been transformed.

会议主页

2018 China Summit of Probiota

2018-11-16

Probiota is a group of microorganisms that are claimed to provide health benefits when consumed. The introduction of the concept (but not the term) is generally attributed to Nobel laureate ?lie Metchnikoff, who postulated that yogurt-consuming Bulgarian peasants lived longer lives because of this custom.

会议主页

2018 ( 10th ) International Conference on Stem Cells

2018-11-09

After nearly 20 years' development, there have been almost 100 companies focusing on technology R&D on stem cells, establishment of stem cell banks and application of stem cells. This conference will facilitate communication and cooperation among researchers at home and abroad.

会议主页

2018 International Forum on Innovative Drug R&D

2018-11-02

With a population of 1.3 billion people and a rapidly expanding economy, China has recently risen to become the third largest pharmaceutical market globally. Several multinational pharmaceutical companies have now located R&D centres in China, and Chinese pharmaceutical companies are increasingly focusing on innovative drug R&D.

会议主页

2018 International Forum on Rare Diseases and Orphan Drugs

2018-11-02

In some parts of the world, an?orphan disease?is a rare disease whose rarity means there is a lack of a market large enough to gain support and resources for discovering treatments for it, except by the government granting economically advantageous conditions to creating and selling such treatments.?Orphan drugs are ones so created or sold.

会议主页

2018 International Symposium on Neonatal Hereditary Diseases and Translational Medicine

2018-11-02

Monogenic diseases are frequent causes of neonatal morbidity and mortality, and disease presentations are often undifferentiated at birth. More than 3500 monogenic diseases have been characterized, but clinical testing is available for only some of them and many feature clinical and genetic heterogeneity.

会议主页

2018 International Forum on Biotechnological Drugs

2018-10-26

Biotechnological drugs are a wide group of therapeutic agents obtained by means of genetic engineering methodologies. This forum will provide you with the latest technologies, the whole industry and the market of novel antibodies, antibody drugs, new vaccine development, new vaccine industry, protein modification in China.

会议主页

2018 International Forum on Novel Antibodies

2018-10-26

An?antibody?(Ab), also known as an?immunoglobulin?(Ig),?is a large, Y-shaped?protein?produced mainly by?plasma cells?that is used by the?immune systemto neutralize?pathogens?such as?pathogenic bacteria?and?viruses. The antibody recognizes a unique molecule of the pathogen, called an?antigen, via the?Fab's variable region.

会议主页

2018 International Forum on Novel Vaccines

2018-10-26

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in the future.

会议主页

2018 (3rd) International Symposium on Protein Modification and Diseases

2018-10-26

Protein Modification refers to the?covalent?and generally?enzymatic?modification of?proteins?following?protein biosynthesis, which is of great importance in cell?signaling. Modification of proteins can be experimentally detected by a variety of techniques, including?mass spectrometry,?Eastern blotting, and?Western blotting.

会议主页